4b1890 | Biomin GmbH | Bifidobacterium animalis ssp. animalis DSM 16284, Ligilactobacillus salivarius DSM 16351 and Enterococcus faecium DSM 21913 | Additive compositionPreparation of Bifidobacterium animalis ssp. animalis DSM 16284, Ligilactobacillus salivarius DSM 16351 and Enterococcus faecium DSM 21913 containing a minimum of 10 × 109 CFU/g additive(3:1:6 ratio)Solid formCharacterisation of the active substanceViable cells of Bifidobacterium animalis ssp. animalis DSM 16284, Ligilactobacillus salivarius DSM 16351 and Enterococcus faecium DSM 21913Analytical methodIdentification: DNA sequencing methods or Pulsed Field Gel Electrophoresis (PFGE) - CEN/TS 17697.Enumeration in the feed additive, premixtures, compound feed and water of:- Bifidobacterium animalis ssp. animalis DSM 16284: spread plate method EN 15785
- Ligilactobacillus salivarius DSM 16351: spread plate method EN 15787
- Enterococcus faecium DSM 21913: spread plate method EN 15788
| All poultry species for fatteningAll poultry species reared for layingAll poultry species reared for breeding | - | 1 × 108 | - | 5 × 107 | - | - 1.In the directions for use of the additive and premixture, the storage conditions and stability to heat treatment shall be indicated.
- 2.The additive may be used via water for drinking.
- 3.The additive may be used simultaneously with the following coccidiostats, in accordance with their respective conditions of authorisation as feed additives: maduramicin ammonium, diclazuril, robenidine hydrochloride, decoquinate, narasin, nicarbazin, a combination of narasin with nicarbazin.
- 4.For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from their use. Where those risks cannot be eliminated by such procedures and measures, the additive and premixtures shall be used with personal breathing and skin protective equipment.
| 12.5.2034 |